AQP4 and glioblastoma: Various studies have confirmed that AQP4 plays a vital role in GBM’s malignant progression and drug resistance (Valente et al., 2022), but its molecular mechanism still needs more in-depth and comprehensive research (Peng et al., 2020; Behnam et al., 2022).